Magazine Article | February 25, 2015

NeuroPhage Pharmaceuticals

Source: Life Science Leader
wayne koberstein

By Wayne Koberstein, Executive Editor, Life Science Leader magazine
Follow Me On Twitter @WayneKoberstein

Targeting a common amyloid structure of misfolded proteins in neurodegenerative diseases such as Alzheimer’s, Parkinson’s — and perhaps many others